« Previous
Next »
Placenta
Volume 29, Issue 9
, Pages 826-832
, September 2008
T Lymphocytes are Targets for Platelet- and Trophoblast-Derived Microvesicles During Pregnancy
References
- . Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006;107:102–108
- . Cellular microparticles: what are they bad or good for?. J Thromb Haemost. 2003;1:1655–1662
- . Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21:157–171
- . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–579
- The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci U S A. 2005;102(8):2892–2897
- . The role of microparticles in inflammation and thrombosis. Scand J Immunol. 2007;66:159–165
- . Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today. 1993;14(7):353–356
- . TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol. 2004;134(2):93–119
- . Histamine regulates placental cytokine expression—in vivo study on HDC knockout mice. Placenta. 2007;28:239–244
- . Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy. J Immunol. 2008;180:2367–2375
- . Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?. Am J Obstet Gynecol. 2002;187:450–456
- . Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol. 2000;18:367–391
- . Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5(3):266–271
- . Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol. 2006;56(5–6):345–355
- . Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol. 2006;176(3):1534–1542
- Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;27(1):56–61
- Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case–controlled study. Hum Reprod. 2004;19(1):191–195
- . Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol. 2007;76(1–2):61–67
- . Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta. 2008;29(S1):73–77
- Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678–2683
- http://www.bdbiosciences.com/pharmingen/protocols
- http://www.sigmaaldrich.com/sigma/datasheet/p7458dat.pdf
- . Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol. 2002;187:1686–1693
- . First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod. 2004;10:55–63
- . Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod. 2005;11:35–41
- . Platelets: signalling cells in the immune continuum. Trends Immunol. 2004;25(9):489–495
- . Formation and fate of platelet microparticles. Blood Cells Mol Dis. 2006;36:182–187
- Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost. 2003;89:486–492
- . Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol. 2003;33:522–531
- . Leukocyte–leukocyte interactions mediated by platelet microparticles under flow. Blood. 2004;95(4):1317–1323
- . STAT3 is a serine kinase target in T lymphocytes. J Biol Chem. 1997;272(39):24542–24549
- . Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum. 2005;52(11):3337–3348
- . Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. Clin Endocrinol Metab. 1999;84:2188–2194
- . Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007;178(9):5949–5956
- Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta. 2007;28:928–935
- . Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006;48(2):180–186
- . HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol. 2000;30(2):586–593
- . How does the maternal immune system contribute to the development of pre-eclampsia?. Placenta. 2007;28:S51–S56
- . Haemostatic changes in pregnancy. Thromb Res. 2004;114(5–6):409–414
- P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol. 2007;8:882–892
- . STAT signalling in cell proliferation and in development. Curr Opin Genet Dev. 2000;10(5):503–507
- . Pre-eclampsia, the placenta and the maternal systemic inflammatory response. Placenta. 2003;24:S21–S27
PII: S0143-4004(08)00187-2
doi: 10.1016/j.placenta.2008.06.006
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
Placenta
Volume 29, Issue 9
, Pages 826-832
, September 2008
